Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives
- 5 May 2010
- journal article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 25 (5) , 730-736
Abstract
Despite being an ancient disease, tuberculosis (TB) remains the leading single-agent infectious disease killer in the world. The emerging serious problem of TB control and clinical management prompted us to synthesize a novel series of heterocyclic substituted diphenyl ether derivatives and determine their activity against the H37Rv strain of Mycobacterium. All ten compounds inhibited the growth of the H37Rv strain of Mycobacterium at concentrations of 1 μg/mL. This activity was found to be comparable to the reference drugs rifampicin and isoniazid at the same concentration. While the antimicrobial activity of other diphenyl ether analogues, such as triclosan, is associated with the inhibition of enoyl-ACP reductase (ENR), the synthesised substituted diphenyl ether derivatives did not affect this enzyme activity in spite of their structural similarity with triclosan. Therefore, these compounds appear to have a novel mechanism of action against M. tuberculosis, and their structural features should be studied further for their potential as new antitubercular drugs.Keywords
This publication has 33 references indexed in Scilit:
- Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivativesEuropean Journal of Medicinal Chemistry, 2009
- A Pathogenic Fungi Diphenyl Ether Phytotoxin Targets Plant Enoyl (Acyl Carrier Protein) ReductasePlant Physiology, 2008
- Tuberculosis control in the era of HIVNature Reviews Immunology, 2005
- Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase IJournal of Bacteriology, 2002
- Kinetic Determinants of the Interaction of Enoyl-ACP Reductase from Plasmodium falciparum with Its Substrates and InhibitorsBiochemical and Biophysical Research Communications, 2001
- Crystallographic analysis of triclosan bound to enoyl reductaseJournal of Molecular Biology, 1999
- Structural basis and mechanism of enoyl reductase inhibition by triclosanJournal of Molecular Biology, 1999
- Biochemistry and molecular genetics of cell‐wall lipid biosynthesis in mycobacteriaMolecular Microbiology, 1997
- The Enoyl‐[Acyl‐Carrier‐Protein] Reductase (FabI) of Escherichia coli, which Catalyzes a Key Regulatory Step in Fatty Acid Biosynthesis, Accepts NADH and NADPH as Cofactors and is Inhibited by Palmitoyl‐CoAEuropean Journal of Biochemistry, 1996
- Antimicrobial Spectrum of Triclosan, a Broad-Spectrum Antimicrobial Agent for Topical ApplicationDermatology, 1979